The ESC guidelines recommend anti-aldosterone medication in patients with a history of myocardial infarction, with EF ≤40%, with heart failure or diabetes, and without renal failure or hyperkalemia, along with treatment with ACE inhibitors and beta-blockers [54]. The gene discussed is ACE; the disease is diabetes mellitus.